Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
BMC Infectious Diseases|April 18, 2023
Clinical outcomes of antimicrobial resistance in cancer patients: a systematic review of multivariable modelsAnders Skyrud Danielsen, Léa Franconeri, Samantha Page, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 5, 2025
Allogeneic stem cell transplantation for patients with lymphoma 2011-21Hege Melby Frøen, Marianne Brodtkorb, Harald Holte, et al.European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|December 1, 2025
Perceptions of safety in hospital at home following allogeneic haematopoietic stem cell transplantation: A qualitative studySigrid Cecilie Tinglum Skøyeneie, Hilde Skuterud Wik, Geir Erland Tjønnfjord, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 15, 2023
[Chronic graft-versus-host disease]Synne Dragesund Rørvik, Ingerid Weum Abrahamsen, Anders Eivind Myhre, et al.Ejhaem|February 26, 2024
Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factorsB Linder Grønvold, Maryan Mohamed Ali, Tor Å Myklebust, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 21, 2026
Vaccination of immunosuppressed patientsMarton König, Trygve Holmøy, Gro Owren Nygaard, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 15, 2023
Allogeneic stem cell transplantation in adults 2015-21Camilla Dao Vo, Anders Eivind Myhre, Ingerid Weum Abrahamsen, et al.Nature Microbiology|April 13, 2026
Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donorAnders Eivind Myhre, Malin Holm Meyer-Myklestad, Hanne Hestdal Gullaksen, et al.Bone Marrow Transplantation|December 24, 2025
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithmAlexandros Rampotas, Jose Maria Aspa-Cilleruelo, Linda Koster, et al.Blood Advances|February 2, 2026
Allogeneic Hematopoietic Stem Cell Transplantation in ERCC6L2 DiseaseMarja Hakkarainen, Flore Sicre de Fontbrune, Ilse Kaaja, et al.Pageof 1